The effects of treatment with Sepin-1 that are similar on the four breast cancer cell lines include non-activation of caspases 3 and 7 and downregulation of cell cycle-driving proteins, such as Raf, FoxM1, Plk1, Cdk1, Aurora A, Lamin B1, and pericentrin. This evidence concerns the gene CASP3 and breast cancer.